|
|
Volumn 5, Issue 4, 2014, Pages 250-251
|
|
2013 Statistics for global prescription medications: CNS Therapeutics maintain a leading position among small molecule therapeutics
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ARIPIPRAZOLE;
BEVACIZUMAB;
DULOXETINE;
EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ESOMEPRAZOLE;
ETANERCEPT;
FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE;
GLATIRAMER;
IMATINIB;
INFLIXIMAB;
INSULIN GLARGINE;
PREGABALIN;
PRESCRIPTION DRUG;
RANIBIZUMAB;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RITUXIMAB;
ROSUVASTATIN;
SITAGLIPTIN;
TIOTROPIUM BROMIDE;
TRASTUZUMAB;
ANTINEOPLASTIC AGENT;
BIOLOGICAL PRODUCT;
CENTRAL NERVOUS SYSTEM AGENTS;
CENTRAL NERVOUS SYSTEM;
DRUG INDUSTRY;
DRUG MARKETING;
EDITORIAL;
HUMAN;
PRESCRIPTION;
PRIORITY JOURNAL;
STATISTICS;
ECONOMICS;
INTERNATIONAL COOPERATION;
STATISTICS AND NUMERICAL DATA;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL PRODUCTS;
CENTRAL NERVOUS SYSTEM AGENTS;
DRUG INDUSTRY;
INTERNATIONALITY;
PRESCRIPTION DRUGS;
|
|
EID: 84899029447
PISSN: None
EISSN: 19487193
Source Type: Journal
DOI: 10.1021/cn500063v Document Type: Editorial |
|
Times cited : (17)
|
|
References (5)
|
